We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$225B
1-Year Est. Return
49.49%
This Fund
S&P 500
This Quarter
Est. Return
+11.74%
1 Year Est. Return
+49.49%
3 Year Est. Return
+172.58%
5 Year Est. Return
+223.9%
10 Year Est. Return
+876%
AUM
$71.5B
AUM Growth
+$3.66B
(+5.4%)
Cap. Flow
-$2.85B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
18.22%
Holding
1,538
New
294
Increased
526
Reduced
448
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$268M |
| 2 |
General Motors
GM
|
+$263M |
| 3 |
AstraZeneca
AZN
|
+$235M |
| 4 |
Vale
VALE
|
+$226M |
| 5 |
Oracle
ORCL
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$945M |
| 2 |
Microsoft
MSFT
|
+$606M |
| 3 |
Canadian Natural Resources
CNQ
|
+$552M |
| 4 |
Bank of America
BAC
|
+$490M |
| 5 |
AbbVie
ABBV
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.7% |
| 2 | Healthcare | 20.13% |
| 3 | Consumer Discretionary | 15.62% |
| 4 | Financials | 9.5% |
| 5 | Energy | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Ecovyst
ECVT
$1.1B
| $824K | ﹤0.01% |
93,042
-577,978
| -86% | -$5.32M |
|
1052
OneSpan
OSPN
$624M
| $816K | ﹤0.01% |
72,907
+53,369
| +273% | +$613K |
|
1053
Clear Secure
YOU
$4.7B
| $814K | ﹤0.01% |
29,691
-67,177
| -69% | -$1.85M |
|
|
TWO
1054
Two Harbors Investment
TWO
$1.26B
| $813K | ﹤0.01% |
51,565
-8,284
| -14% | -$124K |
|
1055
Cinemark Holdings
CNK
$4.37B
| $810K | ﹤0.01% |
+93,482
| New | +$1.05M |
|
1056
Axalta
AXTA
$7.93B
| $805K | ﹤0.01% |
31,605
-196
| -0.6% | -$4.84K |
|
1057
MGM Resorts International
MGM
$11.1B
| $800K | ﹤0.01% |
23,868
-1,861,503
| -99% | -$64.5M |
|
1058
SiriusXM
SIRI
$9.43B
| $800K | ﹤0.01% |
+13,703
| New | +$843K |
|
1059
iShares MSCI Emerging Markets ETF
EEM
$30.5B
| $799K | ﹤0.01% |
21,084
-1,256
| -6% | -$46.3K |
|
1060
Murphy Oil
MUR
$4.99B
| $798K | ﹤0.01% |
18,546
-393,074
| -95% | -$17.7M |
|
|
CHUY
1061
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $796K | ﹤0.01% |
+28,135
| New | +$816K |
|
|
HTB
1062
HomeTrust Bancshares
HTB
$837M
| $793K | ﹤0.01% |
32,794
+14,975
| +84% | +$359K |
|
1063
MetLife
MET
$61.9B
| $784K | ﹤0.01% |
10,833
-183,611
| -94% | -$13.2M |
|
1064
Paylocity
PCTY
$8.1B
| $778K | ﹤0.01% |
+4,004
| New | +$860K |
|
1065
Northrim BanCorp
NRIM
$601M
| $774K | ﹤0.01% |
56,728
| – | – |
|
1066
Canadian National Railway
CNI
$77.2B
| $770K | ﹤0.01% |
6,485
-445,287
| -99% | -$53.2M |
|
|
LOMA
1067
Loma Negra
LOMA
$1.11B
| $765K | ﹤0.01% |
+111,637
| New | +$722K |
|
1068
GoodRx Holdings
GDRX
$1.27B
| $761K | ﹤0.01% |
163,315
-256,214
| -61% | -$1.26M |
|
1069
Petco
WOOF
$817M
| $760K | ﹤0.01% |
+80,178
| New | +$822K |
|
1070
Unifirst Corp
UNF
$5.21B
| $759K | ﹤0.01% |
3,933
+271
| +7% | +$49.6K |
|
1071
Pinnacle West Capital
PNW
$12.2B
| $755K | ﹤0.01% |
9,933
-20,093
| -67% | -$1.44M |
|
1072
Applovin
APP
$105B
| $754K | ﹤0.01% |
+71,606
| New | +$1.05M |
|
|
CCRD
1073
DELISTED
CoreCard
CCRD
| $747K | ﹤0.01% |
+25,790
| New | +$676K |
|
|
DHC
1074
Diversified Healthcare Trust
DHC
$2.03B
| $740K | ﹤0.01% |
+1,143,608
| New | +$1.13M |
|
|
XM
1075
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $739K | ﹤0.01% |
+71,187
| New | +$746K |
|
Similar funds
Arrowstreet Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Arrowstreet Capital held 1,538 positions worth $71.5B, up 5.4% from $67.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $2.85B in Q4 2022, closing 234 positions and reducing 448 holdings. Its most notable exit was AbbVie, an estimated $432M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Gerdau worth $105M.
- Arrowstreet Capital's largest Q4 2022 buy was Gerdau: 23,855,591 shares worth $105M.
- Arrowstreet Capital added most to Visa in Q4 2022, an estimated $268M increase.
- Arrowstreet Capital's biggest Q4 2022 reduction was JPMorgan Chase, cutting an estimated $945M.
- Arrowstreet Capital fully exited AbbVie in Q4 2022, selling an estimated $432M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $71.5B portfolio in Q4 2022.
- Arrowstreet Capital opened 294 new positions and closed 234 in Q4 2022.
- Arrowstreet Capital's portfolio value rose 5.4% quarter-over-quarter to $71.5B.
Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.